Skip to content
← Holders

Sio Capital Management, LLC

What Sio Capital Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1482416 · Filed Nov 16, 2026

Positions
55
Reported value
$528.5M
Opened
15
Closed
19
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$395.2M
    51 positions
  2. Dec 31, 2025$635.7M
    68 positions
  3. Mar 31, 2026$697.3M
    76 positions
  4. Jun 30, 2026$604.3M
    59 positions
  5. Sep 30, 2026$528.5M
    55 positions
SecuritySharesChangeValueOf portfolio
AVRAnteris Technologies Global Corp.
5.2M−6.6%$40.2M7.6%
GMEDGlobus Medical Inc
476.1K+57.7%$35.7M6.7%
GSKGSK PLC
671.1K+53.7%$32.3M6.1%
ICLRIcon PLC
141K+59.9%$24M4.5%
SENSSenseonics Holdings, Inc.
2.3M+43.8%$23.3M4.4%
MRKMerck & Co., Inc.Put option
150KNew$21.8M4.1%
MRKMerck & Co., Inc.
145.5KNew$21.1M4%
IDYAIDEAYA Biosciences, Inc.
500.1K+4.1%$19.2M3.6%
PFEPfizer IncPut option
600KNew$17.1M3.2%
SLSSELLAS Life Sciences Group, Inc.Put option
1.2M±0%$15.1M2.9%
SNYSanofi
356.2K−2.2%$14.7M2.8%
ALLOAllogene Therapeutics, Inc.
9.1M−31.7%$14.6M2.8%
MMSMaximus, Inc.
268.3K−62.5%$14.3M2.7%
RLMDRelmada Therapeutics, Inc.
3.6M+261.7%$13.7M2.6%
VTRSViatris Inc
755.5K−20.8%$13.4M2.5%
AVAHAveanna Healthcare Holdings, Inc.
1M+174.3%$12.6M2.4%
REPLReplimune Group, Inc.
865.3KNew$11.5M2.2%
TNGXTango Therapeutics, Inc.
428.9K+105.7%$10.7M2%
ANIPANI Pharmaceuticals Inc
146.3K+50.3%$10.6M2%
BMRNBioMarin Pharmaceutical Inc
174.3KNew$10.5M2%
CELCCelcuity Inc.
126.3K+14.8%$10M1.9%
AZNAstraZeneca PLC
61.8KNew$10M1.9%
RAPPRapport Therapeutics, Inc.
291.2K−5.3%$9.8M1.9%
VIRVir Biotechnology, Inc.
873.4K−18.8%$9.8M1.8%
CICigna Group
33.9K−41.2%$9.2M1.7%
COOCooper Companies, Inc.
158.1KNew$8.9M1.7%
LQDALiquidia Corp
282KNew$8.5M1.6%
HELPHelus Pharma Inc.
561.3K−56.8%$6.9M1.3%
TARAProtara Therapeutics, Inc.
2M+3.6%$6.1M1.1%
PMVPPMV Pharmaceuticals, Inc.
3.6M+38.0%$6.1M1.1%
AQSTAquestive Therapeutics, Inc.
1.3M−14.0%$5.9M1.1%
PTCTPTC Therapeutics, Inc.
82.9KNew$5.4M1%
CRBPCorbus Pharmaceuticals Holdings, Inc.
766.4KNew$5.2M1%
RNAQURainier Acquisition Corp
500KNew$5.1M1%
HAEHaemonetics CorpPut option
44.7KNew$4.7M0.9%
QTTBQ32 Bio Inc.
529.2KNew$4.4M0.8%
SERSerina Therapeutics, Inc.
2M+100.0%$4M0.8%
DRUGBright Minds Biosciences Inc.
75.2K+1.6%$3.7M0.7%
SVRASavara Inc
657.1K+6.4%$3.4M0.6%
OKUROnKure Therapeutics, Inc.
1.1M+0.4%$3M0.6%
ANTXAN2 Therapeutics, Inc.
548.1K+3.4%$2.9M0.6%
IMNMImmunome Inc.
132.1K+6.4%$2.8M0.5%
ZBIOZenas BioPharma, Inc.
95.5K−54.2%$2.6M0.5%
OVIDOvid Therapeutics Inc.
1M±0%$2.5M0.5%
ALGSAligos Therapeutics, Inc.
327.2K±0%$1.8M0.3%
FULCFulcrum Therapeutics, Inc.
481.6KNew$1.8M0.3%
ALHCAlignment Healthcare, Inc.
184.4KNew$1.5M0.3%
XLOXilio Therapeutics, Inc.
152.5K±0%$1.4M0.3%
EYPTEyePoint, Inc.
373.7K−40.0%$1.2M0.2%
QTIQT Imaging Holdings, Inc.
440.4K+2,790.8%$1.1M0.2%
IBIOiBio, Inc.
904.3K±0%$1.1M0.2%
TELATELA Bio, Inc.
636.3K±0%$731.7K0.1%
ENVBEnveric Biosciences, Inc.
330K+83.3%$490.1K0.1%
NMTCNeuroone Medical Technologies Corp
82.8K±0%$85.3K0.1%
MODDModular Medical, Inc.
26.2K±0%$52.4K0.1%